| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 07/28/2004 | EP1440161A2 7118, a human arginine n-methyltransferase family member and uses therefor |
| 07/28/2004 | EP1440062A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles |
| 07/28/2004 | EP1440057A1 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 07/28/2004 | EP1439878A2 Method and apparatus for dispensing inhalator medicament |
| 07/28/2004 | EP1439863A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 07/28/2004 | EP1439854A2 Conformationally constrained parathyroid hormone (pth) analogs |
| 07/28/2004 | EP1439841A2 Androgen receptor modulators and methods of use thereof |
| 07/28/2004 | EP1439838A1 Macrolides containing pharmaceutical compositions |
| 07/28/2004 | EP1439837A1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 07/28/2004 | EP1439831A1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect |
| 07/28/2004 | EP1439818A1 Chewable tablet containing lysine |
| 07/28/2004 | EP1223990B1 Formulations of hyaluronic acid for delivery of osteogenic proteins |
| 07/28/2004 | EP0927183B1 Spirocyclic metalloprotease inhibitors |
| 07/28/2004 | EP0912741B1 T-cell selective interleukin-4 agonists |
| 07/28/2004 | CN1516739A Use of HMG fragments as anti-inflammatory agents |
| 07/28/2004 | CN1516700A Substituted 4H-chromenes and analogs as activators ofgasp ases and inducers of apoptosis and use thereof |
| 07/28/2004 | CN1516698A Arylindenopyridines with PDE inhibiting activity |
| 07/28/2004 | CN1516691A Phenylpyridine carbonyl piperazine derivative |
| 07/28/2004 | CN1516687A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 07/28/2004 | CN1516594A Preventives of remedies for arthritis |
| 07/28/2004 | CN1516592A Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancers, diabetes, premenstrual syndrome and transdermal transport |
| 07/28/2004 | CN1516587A Quinazoline derivatives capable of promoting release of parathyroid |
| 07/28/2004 | CN1516580A Sulfonamides |
| 07/28/2004 | CN1515672A Human chemotactic factor beta-8, chemotactic factor beta-1 and macrophage inflammatory protein-4 |
| 07/28/2004 | CN1515570A Preparation method of pyrazolo [4,3-C] pyridine-3-ketone L-tartate |
| 07/28/2004 | CN1515548A Oxaminic acid used as thyroid gland receptor ligand and its derivative |
| 07/28/2004 | CN1515524A Method for extracting isoflavone, flavones and lactone from armenica sibirica leaf by adoptnig solvent method |
| 07/28/2004 | CN1515523A Method for extracting isoflavone, flavones and lactone from armeniaca sibirica leaf by adopting resin method |
| 07/28/2004 | CN1515317A Combined therapeutic method for osteoporosis |
| 07/28/2004 | CN1515316A Combined therapeutic method for osteoporosis |
| 07/28/2004 | CN1515306A Medicine for curing necrosis of femoral head |
| 07/28/2004 | CN1515300A Medicine for curnig rheumatoid disease |
| 07/28/2004 | CN1515273A Medicine for curing cervical spondylopathy and its preparation |
| 07/28/2004 | CN1515270A Processing techique of medicinal health-care deer bone glue product |
| 07/28/2004 | CN1515269A Application of ivory powder for curing bone tuberculosis and osteomyelitis |
| 07/28/2004 | CN1515258A Combined therapeutic method for osteoporosis |
| 07/28/2004 | CN1515254A Combined therapeutic method for osteoporosis |
| 07/28/2004 | CN1515251A Composition with function of beautifying face and its application |
| 07/28/2004 | CN1159318C Metal protease inhibitor, preparing process thereof and pharmaceutical composition contg. same |
| 07/28/2004 | CN1159295C Inhibitors of metalloproteinases |
| 07/28/2004 | CN1159048C Process for preparing patch 'Jingubitong' |
| 07/28/2004 | CN1159034C Hongsheng plaster for treating fracture and its preparing process |
| 07/28/2004 | CN1159032C Exterior-applied plaster for treating lumber vertebra disease, cervical vertebra disease and osteoarthropathy and ite preparing process |
| 07/28/2004 | CN1159023C Jiangu Capsule for strengthening bone |
| 07/27/2004 | US6768026 Hormone inhibitors comprising carbocyclic ketones such as 3-(5-methoxyheptyl)-2-cyclohexenone used for prophylaxis of acne, alopecia, keloids or osteoarthritis |
| 07/27/2004 | US6768019 Enzyme inhibitors, 1-(4-methanesulfonyl-benzylidene)-3,4-dihydro-1h-naphthalene-2 -one oxime |
| 07/27/2004 | US6767916 Chalcone coumarins |
| 07/27/2004 | US6767908 Treatment of cytokine mediated diseases such as arthritis. |
| 07/27/2004 | US6767906 Inhibit p34cdc2/cyclin bcdc13 kinase and protein tyrosine kinase pp60c-src and can be used for treatment of hyperproliferative diseases, for example chemotherapy of tumours or osteoporosis. |
| 07/27/2004 | US6767736 Human ion channel protein and polynucleotides encoding the same |
| 07/27/2004 | US6767555 A cyclosporin-containing composition in the form of a capsule consists of a polyoxyethylene sorbitan fatty acid ester, a reaction product of a natural or hydrogenated castor oil, ethylene oxide, a sorbitan fatty ester, and ethanol |
| 07/27/2004 | US6767020 Suspension bushing, motor vehicle and a suspension cross-member for a motor vehicle |
| 07/27/2004 | CA2251197C The use of mmp-13 selective inhibitors for the treatment of osteoarthritis and other mmp-mediated disorders |
| 07/22/2004 | WO2004060892A1 Fused n-containing heterocyclic compounds and medicinal use thereof |
| 07/22/2004 | WO2004060883A1 Pyrimidine-4,6-dicarboxylic acid diamides for use as selective mmp 13 inhibitors |
| 07/22/2004 | WO2004060881A1 1,3-benzothiazinone derivatives, process for producing the same and use thereof |
| 07/22/2004 | WO2004060875A1 Alkynyl-substituted azasugar derivative and drug containing the same as the active ingredient |
| 07/22/2004 | WO2004039978A3 Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 07/22/2004 | WO2004039313A3 Preventing desensitization of receptors |
| 07/22/2004 | WO2003103583A8 A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system |
| 07/22/2004 | WO2003072135A3 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 07/22/2004 | WO2003070675A3 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 07/22/2004 | WO2003059293A3 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
| 07/22/2004 | WO2003017919A3 Composition comprising wenguanguo extracts, methods for preparing same and uses therof |
| 07/22/2004 | WO2002088090A3 Pyrazole derived kinase inhibitors |
| 07/22/2004 | US20040143859 Novel proteins and methods for producing the proteins |
| 07/22/2004 | US20040143115 e.g., 1-[2-Benzoxazol-2-ylaminomethyl)-piperidin-1-yl]-1-(2-methyl-5phenyl-thiazol4-yl)-methanone; used to treat disorders where an antagonist of a human orexin receptor is required |
| 07/22/2004 | US20040143017 Methods of treating osteoarthritis with inducible nitric oxide synthase inhibitors |
| 07/22/2004 | US20040143001 Using photodynamic compound; bactericides, fungicides, viricides; killing microorganisms |
| 07/22/2004 | US20040142999 Novel compounds and compositions as cathepsin inhibitors |
| 07/22/2004 | US20040142988 Bladder diseases; bone diosrders; central nerevous system diosrders |
| 07/22/2004 | US20040142982 Urea derivatives as integrin alpha 4 antagonists |
| 07/22/2004 | US20040142979 Cardiovascular disorders; respiratory system disorders; kidneys; liver diosrders; central nervous system diosrders; osteoarthritis; antiarthritic agents; antitumor agents; multiple sclerosis |
| 07/22/2004 | US20040142976 Modulation cytokine sensitive diseases, cellular adhesion molecules; Aids therapy; antihistamines; antiarthritic agents; bone disorders; malaria; cachexia; Crohn's disease |
| 07/22/2004 | US20040142963 Cardiovascular disorders |
| 07/22/2004 | US20040142961 Utilization of substituted imidazo[1,2-a]-pyridine compounds in pharmaceutical formulations |
| 07/22/2004 | US20040142954 Antiinflammatory agents; antihistamines; Alzheimer's disease; anticholesterol agents; cardiovascular disorders; inflammatory bowel disorders; antitumor agents; antidiabetic agents; brain disorders; multiple sclerosis |
| 07/22/2004 | US20040142950 Amide and ester matrix metalloproteinase inhibitors |
| 07/22/2004 | US20040142947 Pyrrolopyrimidines |
| 07/22/2004 | US20040142945 Antiarthritic agents; multiple sclerosis ; organ rejection ; antidiabetic agents; inflammatory bowel disorders; antiischemic agents; skin disorders |
| 07/22/2004 | US20040142934 treatment of rheumatoid arthritis and/or pain; INHIBIT activity of VEGF receptor tyrosine kinase and VEGF-dependent cell proliferation |
| 07/22/2004 | US20040142932 treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase activity |
| 07/22/2004 | US20040142931 inhibit the tyrosine kinase activity of growth factor receptors such as HER1, HER2, and HER4 |
| 07/22/2004 | US20040142927 Inhibitors of p38 |
| 07/22/2004 | US20040142920 acute or chronic transplant rejection or inflammatory or autoimmune diseases |
| 07/22/2004 | US20040142919 Benzazepinone alpha vintegrin receptor antagonists |
| 07/22/2004 | US20040142877 Ligands of the $g(a)v$g(b)6 integrin |
| 07/22/2004 | US20040142871 Osteoporosis treatment |
| 07/22/2004 | US20040142863 modified aggrecanases, nucleotides encoding such enzymes, and processes for producing these enzymes with improved stability; treatment of osteoarthritis |
| 07/22/2004 | US20040142472 Gene delivery vectors with cell type specificity for primary human chondrocytes |
| 07/22/2004 | US20040142465 Injectable hyaluronic acid derivative with pharmaceuticals/cells |
| 07/22/2004 | US20040142445 Novel metalloprotease having aggrecanase activity |
| 07/22/2004 | US20040142432 Preparing single chain antibodies comprised of camelid subunits for treating and preventing inflammation, allergies, cancer, infections, transplant rejection, autoimmune and muscular disorders |
| 07/22/2004 | US20040142431 Nucleotide sequences comprising restriction fragment length polymorphisms coding polypeptide with antiproliferative, antiviral and antiparasitic effects |
| 07/22/2004 | US20040142426 Novel proteins and methods for producing the proteins |
| 07/22/2004 | US20040142349 kit for detecting a risk of cancer, coronary or cerebrovascular disease, hypertension, type 2 diabetes, dementia, joint arthrosis, cataract, or sensitivity to organophosphorus compounds |
| 07/22/2004 | US20040142348 solid phase synthesis; for diagnosis/treatment/prophyaxis; animal models; genetic engineering |
| 07/22/2004 | US20040141997 Methods for treating or preventing infections from coagulase-negative staphylococci |
| 07/22/2004 | US20040141982 Use of genetically engineered antibodies to treat multiple myeloma |
| 07/22/2004 | US20040141967 Methods and compositions for treating macrophage-mediated diseases |